L'hyperméthylation de DOK1 n'a pas d'effet sur son niveau d'expression dans les tumeurs ovariennes : corrélation du niveau d'expression de DOK1 avec la survie des patientes du cancer ovarien

Authors: Mercier, Pierre-Luc
Advisor: Bachvarov, Dimcho
Abstract: The molecular basis of the epithelial ovarian cancer (EOC) initiation and progression are still poorly understood. A key pathogenic element in cancer is the inactivation of tumours suppressor genes, frequently due to the hypermethylation of their promoter sequence. In this context, we used an epigenomic approach to identify hypermethylated genes in the EOC. We used the demethylating agent, 5-aza-dC, to reactivate hypermethylated genes in four cells lines of EOC (SKOV3, OVCAR3, TOV112 and TOV21). We identified several targets genes potentially hypermethylated that could play a functional role in ovarian tumorigenesis suppression, apoptosis or DNA repair. We evaluated their methylation status by MSP (methylation-specific PCR) and BSP (bisulfite-sequencing PCR) within normal and tumoral ovarian samples and in two EOC cells lines. Among these targets, the DOK1 gene showed an evidence of methylation of the promoter region in the tumour samples compared to the normal ones. Clones over-expressing and others under-expressing DOK1 were built and validated. The potential role of this gene in cellular proliferation, sensitivity to taxol and cisplatin, and in the cell cycle was evaluated by functional studies and a little implication of the DOK1 gene was detected in these functions. The global expression changes connected to the expression of the DOK1 gene were also analyzed by the microarray genomics technology. Our data show that DOK1 is affected by hypermethylation of its potential promoter region in EOC tumors. This hypermethylation do seems not to influence its expression levels. On the contrary, its expression level increases in ovarian cancer. This increase would be connected to a reduction in the risks of progression of the COE. Moreover, this observation confirms the potential role of DOK1 as tumor suppressor in EOC.
Document Type: Mémoire de maîtrise
Issue Date: 2010
Open Access Date: 17 April 2018
Permalink: http://hdl.handle.net/20.500.11794/22083
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
SizeFormat 
27732.pdf3.2 MBAdobe PDFView/Open
All documents in CorpusUL are protected by Copyright Act of Canada.